RE:How long ?It sounds like this an IIROC decision not to let it trade until further clarification of the deal. This is one of those deals that smells fishy and I am guessing IIROC wants to fully vet it. It is hard to believe that a company with an 18 million market cap sold the rights to a drug for 120 million ($300 million x 40%). I hope for shareholders sake that this isnt the case.